Join
Live feed
·
PRReleasevia Quantisnow
Microbot Medical Inc. logo

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

ByQuantisnow·Wall Street's wire, on your screen.
MBOT· Microbot Medical Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MBOT (Microbot Medical Inc.) and more on Quantisnow.